The John A. Moran Eye Center鈥檚 Uveitis Division took shape in 2003. Albert T. Vitale, MD, Akbar Shakoor, MD, and Marissa B. Larochelle, MD, comprise the only uveitis division between...
Clinical updates from the John A. Moran Eye Center鈥檚 Uveitis Division, including a new CMV screening protocol, managing patient care amid the COVID-19 pandemic, ongoing clinical trials, and selected research...
In resource-poor countries such as Myanmar, which has the second-highest number of people living with HIV in Southeast Asia, the rates of cytomegalovirus (CMV) retinitis and associated vision-threatening complications remain...
An oxysterol that accumulates in the eye with age can transform choroidal endothelial cells; interfering with the process might help patients with treatment-resistant age-related macular degeneration.
One of ophthalmology鈥檚 most prestigious research societies and other prominent organizations are tapping John A. Moran Eye Center physician-scientist Mary Elizabeth Hartnett, MD, for leadership roles in 2021 as her...
The John A. Moran Eye Center鈥檚 Global Outreach Division has expanded its donor-funded local care for uninsured and under-insured Utahns to patients with diabetes and other sight-threatening retinal conditions.
Paul S. Bernstein, MD, PhD, is investigating how lipids known as VLC-PUFAs could be used to prevent eye disease thanks to a new way to synthesize them for research.
